Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Inspire Medical Systems, Inc. INSP

Set alert

Price alert · INSP

All alert types
67.21 USD 0.00 0.00%

At close

67.21 0.00 0.00%

Pre-market · Nov 3, 7:29 AM ET

Bid
67.15 × 300
Ask
67.71 × 100
65.80 Day range 69.29
38.91 52-week range 147.03
YTD
-27.13%
1 year
-6.76%
Open
68.71
Prev close
67.21
Mkt cap
1.94B
Vol
1.08M
Avg vol
776.16K
EPS
4.54
P/E
14.80
Div yield
0.00%
More statistics
Low
65.80
High
69.29
Forward P/E
43.72
Beta
0.65
Short ratio
4.74
Inst. own
128.14%
Dividend
0.00
Ex-div date
Earnings
Feb 10, 2027
50-d avg
68.59
200-d avg
58.57
1y target
68.00

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Nov 3, 2025Earnings: 0.38; estimate -0.15; surprise 353.33%
  • Feb 11, 2026Earnings: 1.65; estimate 0.69; surprise 139.13%
  • May 4, 2026Earnings: 0.1; estimate -0.27533; surprise 136.32%
  • Aug 3, 2026Earnings: 0.14; estimate -0.23592; surprise 159.34%
  • Sep 11, 2026Rating: Stifel · Buy → Buy
  • Sep 21, 2026Rating: Freedom Capital Markets · Buy → Buy
  • Oct 1, 2026Rating: RBC Capital · Sector Perform → Sector Perform
  • Oct 2, 2026Rating: Freedom Capital Markets · Buy → Buy
  • Oct 7, 2026Rating: Barclays · — → Underweight
  • Oct 14, 2026Rating: Truist Securities · Hold → Hold
  • Nov 2, 2026Earnings: 0.14; estimate 0.08701; surprise 60.9%
Signals (148)
NameDateAgo
SMA: BearishOct 26, 20261 week ago
SMA: BullishAug 3, 20263 months ago
SMA: BullishJun 22, 20264 months ago
MACD: Buy SignalJun 8, 20264 months ago
RSI: OversoldMay 11, 20265 months ago
MACD: Sell SignalMay 4, 20266 months ago
MACD: Buy SignalApr 27, 20266 months ago
MACD: Sell SignalJan 26, 20269 months ago
SMA: BearishDec 15, 202510 months ago
SMA: BearishDec 15, 202510 months ago
SMA: BullishNov 24, 202511 months ago
SMA: BullishNov 3, 20251 year ago
MACD: Buy SignalOct 27, 20251 year ago
RSI: OversoldSep 1, 20251 year ago
RSI: OversoldAug 4, 20251 year ago
SMA: BearishFeb 3, 20251 year ago
SMA: BearishFeb 3, 20251 year ago
SMA: BullishJan 27, 20251 year ago
SMA: BullishJan 20, 20251 year ago
SMA: BearishJan 13, 20251 year ago

Newest 20 of 148.

Financial health

Altman Z-Score

10.67 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A+5 / 5 overall

  • DCF 5
  • Return on Equity 4
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 3
  • P/B 4

Valuation

P/E 18.6×
FY 2016: -16.8×FY 2017: -19.2×FY 2018: -28.2×FY 2019: -53.0×FY 2020: -85.9×FY 2021: -149×FY 2022: -157×FY 2023: -283×FY 2024: 103×FY 2025: 18.6×
FY 2016 5y median -149× FY 2025
P/S 3.0×
FY 2016: 19.0×FY 2017: 11.8×FY 2018: 12.2×FY 2019: 21.5×FY 2020: 42.5×FY 2021: 26.9×FY 2022: 17.3×FY 2023: 9.5×FY 2024: 6.9×FY 2025: 3.0×
FY 2016 5y median 9.5× FY 2025
P/B 3.5×
FY 2016: -47.1×FY 2017: 227×FY 2018: 3.8×FY 2019: 12.6×FY 2020: 21.3×FY 2021: 27.4×FY 2022: 14.3×FY 2023: 10.4×FY 2024: 8.0×FY 2025: 3.5×
FY 2016 5y median 10.4× FY 2025
P/FCF 34.5×
FY 2016: -17.1×FY 2017: -20.8×FY 2018: -32.5×FY 2019: -49.6×FY 2020: -88.4×FY 2021: -253×FY 2022: 2859×FY 2023: 5821×FY 2024: 60.5×FY 2025: 34.5×
FY 2016 5y median 60.5× FY 2025
EV/EBITDA 33.0×
FY 2016: -18.7×FY 2017: -22.3×FY 2018: -30.0×FY 2019: -59.6×FY 2020: -87.6×FY 2021: -158×FY 2022: -163×FY 2023: -340×FY 2024: 83.0×FY 2025: 33.0×
FY 2016 5y median -158× FY 2025
EV/Sales 2.9×
FY 2016: 19.5×FY 2017: 12.1×FY 2018: 10.7×FY 2019: 21.6×FY 2020: 41.1×FY 2021: 26.1×FY 2022: 16.3×FY 2023: 9.3×FY 2024: 6.7×FY 2025: 2.9×
FY 2016 5y median 9.3× FY 2025
FCF Yield 2.9%
FY 2016: -5.9%FY 2017: -4.8%FY 2018: -3.1%FY 2019: -2.0%FY 2020: -1.1%FY 2021: -0.4%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 1.7%FY 2025: 2.9%
FY 2016 5y median 0.0% FY 2025

Profitability

Gross Margin 85.4%
FY 2016: 76.2%FY 2017: 78.9%FY 2018: 80.1%FY 2019: 83.4%FY 2020: 84.7%FY 2021: 85.7%FY 2022: 83.8%FY 2023: 84.5%FY 2024: 84.7%FY 2025: 85.4%
FY 2016 5y median 84.7% FY 2025
Operating Margin 5.6%
FY 2016: -105.0%FY 2017: -56.0%FY 2018: -40.3%FY 2019: -42.5%FY 2020: -48.7%FY 2021: -17.1%FY 2022: -11.7%FY 2023: -6.4%FY 2024: 4.5%FY 2025: 5.6%
FY 2016 5y median -6.4% FY 2025
Net Margin 15.9%
FY 2016: -112.8%FY 2017: -61.3%FY 2018: -43.1%FY 2019: -40.5%FY 2020: -49.6%FY 2021: -18.0%FY 2022: -11.0%FY 2023: -3.4%FY 2024: 6.7%FY 2025: 15.9%
FY 2016 5y median -3.4% FY 2025
ROE 18.6%
FY 2016: 280.4%FY 2017: -1180.0%FY 2018: -13.3%FY 2019: -23.8%FY 2020: -24.9%FY 2021: -18.4%FY 2022: -9.0%FY 2023: -3.7%FY 2024: 7.8%FY 2025: 18.6%
FY 2016 5y median -3.7% FY 2025
ROIC 6.3%
FY 2016: -188.8%FY 2017: -89.2%FY 2018: -10.8%FY 2019: -21.1%FY 2020: -21.6%FY 2021: -15.1%FY 2022: -9.4%FY 2023: -6.7%FY 2024: 4.6%FY 2025: 6.3%
FY 2016 5y median -6.7% FY 2025
ROA 16.0%
FY 2016: -141.3%FY 2017: -69.8%FY 2018: -10.9%FY 2019: -18.3%FY 2020: -20.3%FY 2021: -14.2%FY 2022: -7.9%FY 2023: -3.1%FY 2024: 6.6%FY 2025: 16.0%
FY 2016 5y median -3.1% FY 2025

Growth (YoY)

Revenue 13.6%
FY 2016: 105.0%FY 2017: 73.9%FY 2018: 77.1%FY 2019: 62.2%FY 2020: 40.6%FY 2021: 102.3%FY 2022: 74.7%FY 2023: 53.2%FY 2024: 28.5%FY 2025: 13.6%
FY 2016 FY 2025
Operating Income 41.2%
FY 2016: 12.9%FY 2017: 7.2%FY 2018: -27.3%FY 2019: -71.2%FY 2020: -61.1%FY 2021: 29.1%FY 2022: -19.4%FY 2023: 15.4%FY 2024: 189.6%FY 2025: 41.2%
FY 2016 FY 2025
EPS (diluted) 179.4%
FY 2016: 12.9%FY 2017: 12.8%FY 2018: -15.4%FY 2019: 6.7%FY 2020: -56.4%FY 2021: 29.7%FY 2022: -3.9%FY 2023: 55.0%FY 2024: 343.1%FY 2025: 179.4%
FY 2016 FY 2025
Free Cash Flow -13.9%
FY 2016: 19.2%FY 2017: 11.2%FY 2018: -16.9%FY 2019: -87.8%FY 2020: -56.0%FY 2021: 55.3%FY 2022: 110.0%FY 2023: -58.6%FY 2024: 8798.7%FY 2025: -13.9%
FY 2016 FY 2025

Financial Health

Current Ratio 6.1×
FY 2016: 1.7×FY 2017: 3.4×FY 2018: 17.9×FY 2019: 10.1×FY 2020: 13.0×FY 2021: 6.5×FY 2022: 8.7×FY 2023: 7.6×FY 2024: 7.1×FY 2025: 6.1×
FY 2016 5y median 7.1× FY 2025
Quick Ratio 4.6×
FY 2016: 1.2×FY 2017: 2.9×FY 2018: 17.6×FY 2019: 9.8×FY 2020: 12.6×FY 2021: 6.1×FY 2022: 8.5×FY 2023: 7.2×FY 2024: 6.2×FY 2025: 4.6×
FY 2016 5y median 6.2× FY 2025
Debt / Equity 0.0×
FY 2016: -2.4×FY 2017: 11.1×FY 2018: 0.2×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -0.9×
FY 2016: -0.5×FY 2017: -0.5×FY 2018: 4.0×FY 2019: -0.1×FY 2020: 3.0×FY 2021: 4.7×FY 2022: 10.4×FY 2023: 9.4×FY 2024: -1.8×FY 2025: -0.9×
FY 2016 5y median 4.7× FY 2025
Interest Coverage 372×
FY 2016: -13.2×FY 2017: -9.1×FY 2018: -6.2×FY 2019: -16.5×FY 2020: -26.6×FY 2021: -18.7×FY 2022: -28.4×FY 2023: 0.0×FY 2024: 1640×FY 2025: 372×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31